Nitrogen monoxide (·NO), commonly referred to as
nitric
oxide
in the biochemical literature [1],
is a free radical generated in biological systems. ·NO functions at low
concentrations as a signal in many diverse physiological processes such
as blood pressure control, neurotransmission, learning and memory, and at high
concentrations as a defensive cytotoxin (see list of
reviews on structure and function of nitric oxide
synthases). Nitric oxide synthase (NOS; EC
1.14.13.39)
enzymes produce ·NO by catalysing a fiveelectron oxidation of a
guanidino nitrogen of Larginine
(LArg). Oxidation of
LArg to Lcitrulline
occurs via two successive monooxygenation reactions producing
N
hydroxyLarginine
as an intermediate (1). 2 mol of O2 and 1.5 mol of NADPH are
consumed per mole of ·NO formed
[2 and references therein].
NOSs are the only enzymes known to simultaneously require five bound
cofactors/prosthetic groups: FAD, FMN, haem,
tetrahydrobiopterin
(BH4) and
Ca2+-calmodulin
(CaM). In mammals, three distinct genes encode NOS isozymes: neuronal (nNOS or
NOS1), cytokineinducible (iNOS or NOS2) and endothelial
(eNOS or NOS3) [3].
Some properties of mammalian NOS isozymes are summarised in the table:





(1)
hydroxyLarginine
| Enzyme | Gene | No. of exons | No. of residues | Subcellular location | Regulation |
|---|---|---|---|---|---|
| nNOS | NOS1 | 29 | 1429-1433 | Mainly soluble (brain); mainly particulate (skeletal muscle) | Ca2+/CaM |
| iNOS | NOS2 | 27 | 1144-1153 | Mainly soluble | Cytokineinducible; Ca2+independent |
| eNOS | NOS3 | 26 | 1203-1205 | Mainly particulate | Ca2+/CaM |
iNOS and nNOS are soluble and found predominantly in the cytosol, while
eNOS is membrane associated. eNOS localisation to endothelial membranes is
mediated by cotranslational Nterminal myristoylation and
posttranslational palmitoylation.
The enzymes exist as homodimers, each monomer consisting of
two major domains: Nterminal oxygenase domain, which belongs to the
class of haem-thiolate proteins, and
Cterminal reductase domain, which is homologous to NADPH:P450 reductase.
The interdomain linker between the oxygenase and reductase domains contains a
CaMbinding sequence.
nNOS contains an additional Nterminal domain (`DHR domain') which shows
homology to syntrophins, a family of dystrophinbinding proteins,
some protein tyrosine phosphatases, protein kinases and some other proteins
[4]. The subcellular localisation of
nNOS in skeletal muscle is mediated by anchoring of nNOS to dystrophin.
A schematic alignment of cofactor binding sites of the three NOS isozymes
follows:
| nNOS | DHR |
|
haem | CaM | FMN | FAD | NADPH | |||||||
| iNOS | haem | CaM | FMN | FAD | NADPH | |||||||||
| eNOS | Myr | haem | CaM | FMN | FAD | NADPH | ||||||||
All NOS isozymes are catalytically selfsufficient.
The electron flow in the ·NO synthase reaction is
CaM binding to nNOS has been shown to regulate catalytic activity by triggering
electron flux from FMN to haem, thereby coupling the oxygenase and reductase
domains. CaM also facilitates NADPHdependent reduction of cytochrome
c and ferricyanide in BH4 and haemdepleted nNOS
(1.2). The continual activity of iNOS is explained by its exceptionally
high avidity for CaM.
CaM

NOS
NADPH
FAD
FMN
haem
O2
(1.1)
The role of reduced pterin cofactor remains unclear (cf. views that
BH4 is required in catalytic
[5] or stoichiometric
[6] quantities).
It was hypothesised that redox cycling
BH4
CaM

CaM

NOS
NADPH
FAD
FMN
Fe3+
(1.2)
BH2
takes place in situ while bound to NOS
[2].
A number of enzyme properties which are thought to involve pterin were
investigated using pterinfree iNOS and different tetrahydro or
dihydropterins. It was found that ·NO synthesis and the ability to increase
haemdependent NADPH oxidation in response to substrates require fully
reduced tetrahydropterins and are independent of side chain structure; in
contrast, pterin binding affinity and its ability to shift the haem iron to
highspin state, stabilise the ferrous haem iron coordination structure,
support haem iron reduction, and promote dimerisation of iNOS subunits
were independent of pterin oxidation state but dependent on pterin side chain
structure or stereochemistry [7].
The 3D structures have been reported for iNOS oxygenase domain
(iNOSox) complexes with the NOS inhibitors imidazole and
aminoguanidine [8], iNOSox dimer
complex with BH4 and LArg
[9], and BH4bound and
BH4free dimers of constitutive eNOS oxygenase domain
(eNOSox) [10]. NOSox has
a novel nonmodular
/ß fold,
resembling "a baseball catcher's mitt for a left hand"
[8]. The fold consists of a winged
ßsheet with projecting ßhairpins and flanking
helices. Haem is situated in
the ßsheet `palm' with its distal face directed toward a large
cavity.
In iNOSox-imidazole complex, the lowspin haem iron is axially
coordinated to proximal Cys194 and to exogenous imidazole.
The LArg analogue aminoguanidine binds in the distal
pocket adjacent to the haem is such a way that one guanidino nitrogen is
directed toward the activated oxygen binding site.
The crystal structure of eNOSox dimer reveals a zinc ion
tetrahedrally coordinated to pairs of symmetryrelated Cys residues at
the dimer interface [10].
| ENZYME | LIGAND | BRENDA | Official name | Alternative names |
|---|---|---|---|---|
| 1.14.13.39 | 1.14.13.39 | 1.14.13.39 | Nitric oxide synthase | NO synthase; NO synthetase; NOS |
| PRINTS ID | PRINTS AC | PROSITE/BLOCKS ID | PROSITE AC | BLOCKS AC |
|---|---|---|---|---|
| FPNCR | PR00371 | |||
| FLAVODOXIN | PR00369 | FLAVODOXIN | PS00201 | BL00201 |
| Protein Superfamily | Protein Homology Domain | Pfam | LPFC 3D alignment |
|---|---|---|---|
| 03633; nitric oxide synthase | 00062; flavodoxin |
PF00175;
oxidored_fad
PF00258; flavodoxin |
| PDB | scop | BSM | RELI Base | Header |
¹ |
|---|---|---|---|---|---|
| 1noc | 1noc | Inducible nitric oxide synthase oxygenase domain ( 114) (complex with type I E. coli chloramphenicol acetyl transferase and imidazole); mouse macrophage (recombinant form expressed in Escherichia coli) | |||
| 1nos | 1nos | Inducible nitric oxide synthase oxygenase domain ( 114) (complex with imidazole); mouse macrophage (recombinant form expressed in Escherichia coli) | |||
| 2nos | 2nos | Inducible nitric oxide synthase oxygenase domain ( 114) (complex with aminoguanidine and imidazole); mouse macrophage (recombinant form expressed in Escherichia coli) |
¹ Macromolecular Structures abstract.
Full text is available to BioMedNet
Members
References
|
| Bibliography on structural studies of nitric oxide synthases |
|
| Reviews on nitric oxide synthases |
|
| The Nitric Oxide Home Page |
|
| Directory of P450containing Systems |